Nur Izzah Nbh
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nur Izzah Nbh has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Aishwarya Jayagopal
Department of Information Systems and Analytics, School of Computing, National University of Singapore, Singapore 117417, Singapore
1 shared publication - Anand Devaprasath Jeyasekharan
Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
1 shared publication - Choon Kiat Ong
Duke-NUS Medical School, Singapore, Singapore
1 shared publication - Dachuan Huang
National Cancer Centre 1 Lymphoma Translational Research Laboratory, Division of Cellular and Molecular Research Singapore, Singapore
1 shared publication - Herty Liany
National Cancer Centre Singapore, Singapore
1 shared publication - Jing Quan Lim
Lymphoma Genomic Translational Research Laboratory, Cellular and Molecular Research, National Cancer Centre Singapore, Singapore, Singapore
1 shared publication
Latest Publications
- 16 January 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 28 (3) , 1785-1796
ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic Interactions
A Synthetic Lethal (SL) interaction is a functional relationship between two genes or functional entities where the loss of either entity is viable but the loss of both is lethal. Such pairs can be used to develop targeted anticancer therapies with fewer side effects and reduced overtreatment. However, finding clinically relevant SL interactions remains challenging. Leveraging unified gene expression data of both disease-free and cancerous samples, we design a new technique based on statistical hypothesis testing, called ASTER, to identify SL pairs. We empirically find that the patterns of mutually exclusivity ASTER finds using genomic and transcriptomic data provides a strong signal of synthetic lethality. For large-scale multiple hypothesis testing, we develop an extension called ASTER++ that can utilize additional input gene features within the hypothesis testing framework. Our computational and functional experiments demonstrate the efficacy of ASTER in identifying SL pairs with potential therapeutic benefits.
- 16 January 2024
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Journal of Biomedical and Health Informatics
- Vol. 28 (3) , 1785-1796
ASTER: A Method to Predict Clinically Relevant Synthetic Lethal Genetic Interactions
A Synthetic Lethal (SL) interaction is a functional relationship between two genes or functional entities where the loss of either entity is viable but the loss of both is lethal. Such pairs can be used to develop targeted anticancer therapies with fewer side effects and reduced overtreatment. However, finding clinically relevant SL interactions remains challenging. Leveraging unified gene expression data of both disease-free and cancerous samples, we design a new technique based on statistical hypothesis testing, called ASTER, to identify SL pairs. We empirically find that the patterns of mutually exclusivity ASTER finds using genomic and transcriptomic data provides a strong signal of synthetic lethality. For large-scale multiple hypothesis testing, we develop an extension called ASTER++ that can utilize additional input gene features within the hypothesis testing framework. Our computational and functional experiments demonstrate the efficacy of ASTER in identifying SL pairs with potential therapeutic benefits.